Detalhe da pesquisa
1.
Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice.
Ann Hematol
; 2024 Apr 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38662203